Differentiation of the immunosuppressive and antiviral effects of interferon.
D000818:Animals; D000914:Antibodies, Viral; D004247:DNA / Q000096:biosynthesis; D004768:Enterotoxins / Q000494:pharmacology; D005260:Female; D006462:Hemolytic Plaque Technique; D007165:Immunosuppression Therapy; D007369:Interferon Inducers / Q000494:pharmacology; D007372:Interferons / Q000276:immunology*; D008213:Lymphocyte Activation; D008623:Mercaptoethanol / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D008934:Mitogens / Q000494:pharmacology; D011063:Poly A-U / Q000494:pharmacology; D012756:Sheep; D013210:Staphylococcus
D000914:Antibodies, Viral; D004768:Enterotoxins; D007369:Interferon Inducers; D008934:Mitogens; D011063:Poly A-U; D008623:Mercaptoethanol; D004247:DNA; D007372:Interferons